<SEC-DOCUMENT>0000950170-25-052627-index.html : 20250410
<SEC-HEADER>0000950170-25-052627.hdr.sgml : 20250410
<ACCEPTANCE-DATETIME>20250409194533
ACCESSION NUMBER:		0000950170-25-052627
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20250409
FILED AS OF DATE:		20250410
DATE AS OF CHANGE:		20250409

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ImmunoPrecise Antibodies Ltd.
		CENTRAL INDEX KEY:			0001715925
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39530
		FILM NUMBER:		25826224

	BUSINESS ADDRESS:	
		STREET 1:		INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701
		BUSINESS PHONE:		6048060626

	MAIL ADDRESS:	
		STREET 1:		INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>press_release_april_9_20.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: press_release_april_9_20.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ipa-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: ipa-ex99_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ipa-ex99_2.htm
<DESCRIPTION>EX-99.2
<TEXT>
Document 3 - file: ipa-ex99_2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>ipa-ex99_3.htm
<DESCRIPTION>EX-99.3
<TEXT>
Document 4 - file: ipa-ex99_3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>ipa-ex99_4.htm
<DESCRIPTION>EX-99.4
<TEXT>
Document 5 - file: ipa-ex99_4.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>6
<FILENAME>ipa-ex99_5.htm
<DESCRIPTION>EX-99.5
<TEXT>
Document 6 - file: ipa-ex99_5.htm

</DOCUMENT>
</SEC-DOCUMENT>